Tonight on Nightly Business Report, Eli Lilly's arthritis drug was expected to be a blockbuster, but the FDA said not so fast. Plus, why Americans are once again swimming in debt.
AZPM is a service of the University of Arizona and our broadcast stations are licensed to the Arizona Board of Regents who hold the trademarks for Arizona Public Media and AZPM. We respectfully acknowledge the University of Arizona is on the land and territories of Indigenous peoples.